Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical Significance of INHBA Gene Expression in Patients with Gastric Cancer who Receive Curative Resection Followed by Adjuvant S-1 Chemotherapy

26 Jun 2017

Abstract excerpt

BACKGROUND: Standard treatment for stage II/III gastric cancer is curative resection followed by adjuvant chemotherapy. However, the five-year survival remains unsatisfactory. Inhibin βA (INHBA) has been reported to be associated with cancer cell proliferation and chemoresistance. PATIENTS AND METHODS: We studied the clinical significance of INHBA gene expression in 134 patients with stage II/III gastric cancer...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Clusterin in disease pathology
Share to NF-κB Signaling Pathways
Share to TGF-β signaling in diseases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 28652421
DOI: 10.21873/invivo.11095

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical Significance of INHBA Gene Expression in Patients with Gastric Cancer who Receive Curative Resection Followed by Adjuvant S-1 ChemotherapyPMID 28652421Read ↗

INHBA gene silencing inhibits gastric cancer cell migration and invasion by impeding activation of the TGF‐β signaling pathwaySemantic proximity Read ↗

Identification of INHBA as a potential biomarker for gastric cancer through a comprehensive analysisSemantic proximity Read ↗

Identification of INHBA as a Potential Biomarker for Gastric Cancer by Comprehensive AnalysisSemantic proximity Read ↗

Inhibin, beta A regulates the transforming growth factor‐beta pathway to promote malignant biological behaviour in colorectal cancerSemantic proximity Read ↗

INHBB is a novel prognostic biomarker and correlated with immune infiltrates in gastric cancerSemantic proximity Read ↗

INHBB Is a Novel Prognostic Biomarker Associated with Cancer‐Promoting Pathways in Colorectal CancerSemantic proximity Read ↗

Inhibin β-A (INHBA) induces epithelial–mesenchymal transition and accelerates the motility of breast cancer cells by activating the TGF-β signaling pathwaySemantic proximity Read ↗

A meta-analysis of the inhibin network reveals prognostic value in multiple solid tumorsSemantic proximity Read ↗

Targeting INHBA in Ovarian Cancer Cells Suppresses Cancer Xenograft Growth by Attenuating Stromal Fibroblast ActivationSemantic proximity Read ↗

A bioinformatic analysis of the inhibin-betaglycan-endoglin/CD105 network reveals prognostic value in multiple solid tumorsSemantic proximity Read ↗

INHBA gene silencing inhibits proliferation, migration, and invasion of osteosarcoma cells by repressing TGF-β signaling pathway activationSemantic proximity Read ↗

Prognostic significance of BMP and activin membrane-bound inhibitor in colorectal cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.